These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23953599)

  • 1. Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025: Re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
    Parker C; Sydes MR; Kynaston H;
    Eur Urol; 2013 Nov; 64(5):e102. PubMed ID: 23953599
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Chris Parker, Matthew R. Sydes and Howard Kynaston's letter to the editor re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
    Abdollah F; Briganti A
    Eur Urol; 2013 Nov; 64(5):e103-4. PubMed ID: 23915876
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039.
    Alongi F; Aiello D; Mazzola R; Cavalleri S
    Eur Urol; 2017 Aug; 72(2):e39-e40. PubMed ID: 28318727
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Gianluca Giannarini, Nazareno Suardi and Alberto Briganti's letter to the editor re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A multinational, multi-institutional study comparing positive surgical margin rates among 22 393 open, laparoscopic, and robot-assisted radical prostatectomy patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.11.018.
    Sooriakumaran P; Wiklund P; Roobol MJ; Steyerberg E; Sanchez-Salas R; Cathelineau X; Tewari AK
    Eur Urol; 2014 Jun; 65(6):e91-2. PubMed ID: 24447573
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.007.
    Wei Y; Ye D; Zhu Y
    Eur Urol; 2022 Aug; 82(2):e51. PubMed ID: 35599186
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Jesse D. Sammon, Firas Abdollah, Anthony D'Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756-65.
    Sammon JD; Abdollah FA; Trinh QD
    Eur Urol; 2016 Jun; 69(6):e129. PubMed ID: 26461111
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Jesse D. Sammon, Firas Abdollah, Anthony D'Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756-65.
    Froehner M; Koch R; Wirth MP
    Eur Urol; 2016 Jun; 69(6):e128. PubMed ID: 26456682
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Christian Bolenz, Stephen J. Freedland, Brent K. Hollenbeck, et al. costs of radical prostatectomy for prostate cancer: a systematic review. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.059.
    Rassweiler J
    Eur Urol; 2013 Apr; 63(4):e53-6. PubMed ID: 23312570
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9.
    Bogdanović J; Sekulić V
    Eur Urol; 2015 Aug; 68(2):e35-6. PubMed ID: 25801051
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038.
    Froehner M; Koch R; Wirth MP
    Eur Urol; 2015 Nov; 68(5):e103. PubMed ID: 26318708
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9: Extended Lymph Node Dissection and the Will Rogers Phenomenon.
    Froehner M; Wirth MP
    Eur Urol; 2015 Jun; 67(6):e112. PubMed ID: 25282364
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9.
    Abdollah F; Montorsi F; Briganti A
    Eur Urol; 2015 Aug; 68(2):e37-8. PubMed ID: 25801052
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002.
    Ates F; Akyol I; Soydan H
    Eur Urol; 2012 Jul; 62(1):e9; author reply e10-1. PubMed ID: 22512903
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038.
    Rieken M; Shariat SF
    Eur Urol; 2015 Nov; 68(5):e104-5. PubMed ID: 26314617
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023: Radical Treatment in Very High-risk Prostate Cancer: Venturing Down a Path Less Travelled.
    Santok GD; Rha KH
    Eur Urol; 2017 Apr; 71(4):e113-e114. PubMed ID: 27717521
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052.
    Williams SB; Ward JF
    Eur Urol; 2016 Sep; 70(3):e77-8. PubMed ID: 26988610
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Roderick C.N. van den Bergh, Massimo Valerio, Derya Tilki, and Giorgio Gandaglia's Letter to the Editor re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2020.02.009.
    Wilt TJ; Dahm P; Brawer MK
    Eur Urol; 2020 Aug; 78(2):e69-e70. PubMed ID: 32303386
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.
    Stephan C; Cammann H; Jung K
    Eur Urol; 2015 Nov; 68(5):e106-7. PubMed ID: 26215600
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Robert J. van Soest and Ronald de Wit's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.
    de Bono J
    Eur Urol; 2017 Jan; 71(1):e11. PubMed ID: 27751730
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.
    van Soest RJ; de Wit R
    Eur Urol; 2017 Jan; 71(1):e9-e10. PubMed ID: 27746063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.